• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 后晚期阶段出现机化性肺炎。

Organising pneumonia manifesting as a late-phase complication of COVID-19.

机构信息

Respiratory Unit, Department of Medicine, Pusat Perubatan Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.

Respiratory Unit, Department of Medicine, Pusat Perubatan Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia

出版信息

BMJ Case Rep. 2021 Oct 29;14(10):e246119. doi: 10.1136/bcr-2021-246119.

DOI:10.1136/bcr-2021-246119
PMID:34716149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8559103/
Abstract

Acute COVID-19 usually lasts 4 weeks from the onset of symptoms. We report two cases of COVID-19-associated organising pneumonia (OP) occurring beyond 4 weeks from the acute onset of symptoms. Both tested positive for SARS reverse transcription-PCR 2 months before presentation with a resolution of respiratory symptoms. The first case presented with residual fatigue and worsening exertional dyspnoea. Chest CT revealed an OP pattern. The second case presented with worsening cough and new-onset pleuritic chest pain with persistent radiological consolidation. A transbronchial lung biopsy confirmed OP. Both patients responded well to 12 weeks of steroid therapy. This case illustrates the rare presentation of OP as a late sequela of COVID-19 and the good response to steroid therapy.

摘要

急性 COVID-19 通常从症状出现开始持续 4 周。我们报告了两例 COVID-19 相关的机化性肺炎(OP),其发生在症状急性发作后超过 4 周。这两例均在出现呼吸道症状前 2 个月 SARS 逆转录-PCR 检测呈阳性,且呼吸症状已缓解。第一例患者表现为残留疲劳和进行性运动性呼吸困难加重。胸部 CT 显示 OP 模式。第二例患者表现为咳嗽加重和新出现的伴有持续性影像学实变的胸膜炎性胸痛。经支气管肺活检证实为 OP。这两例患者均对 12 周的类固醇治疗反应良好。该病例说明了 OP 作为 COVID-19 的罕见后遗症,以及对类固醇治疗的良好反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/8559103/7659e440db28/bcr-2021-246119f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/8559103/7644c41511c7/bcr-2021-246119f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/8559103/e6678aa460df/bcr-2021-246119f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/8559103/7ef400a778d1/bcr-2021-246119f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/8559103/7659e440db28/bcr-2021-246119f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/8559103/7644c41511c7/bcr-2021-246119f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/8559103/e6678aa460df/bcr-2021-246119f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/8559103/7ef400a778d1/bcr-2021-246119f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/8559103/7659e440db28/bcr-2021-246119f04.jpg

相似文献

1
Organising pneumonia manifesting as a late-phase complication of COVID-19.COVID-19 后晚期阶段出现机化性肺炎。
BMJ Case Rep. 2021 Oct 29;14(10):e246119. doi: 10.1136/bcr-2021-246119.
2
A rare cause of secondary organising pneumonia.继发性机化性肺炎的罕见病因。
BMJ Case Rep. 2021 Mar 5;14(3):e241737. doi: 10.1136/bcr-2021-241737.
3
Bronchiolitis obliterans-organizing pneumonia: an Italian experience.闭塞性细支气管炎伴机化性肺炎:意大利的经验。
Respir Med. 2000 Jul;94(7):702-8. doi: 10.1053/rmed.2000.0805.
4
Acute fibrinous organising pneumonia presenting as a cavitary lung lesion and treatment response to azithromycin.表现为肺空洞性病变的急性纤维蛋白性机化性肺炎及对阿奇霉素的治疗反应
BMJ Case Rep. 2019 Aug 21;12(8):e230868. doi: 10.1136/bcr-2019-230868.
5
Chest CT imaging features for prediction of treatment response in cryptogenic and connective tissue disease-related organizing pneumonia.胸部 CT 影像学特征预测隐源性及结缔组织病相关机化性肺炎的治疗反应。
Eur Radiol. 2020 May;30(5):2722-2730. doi: 10.1007/s00330-019-06651-5. Epub 2020 Feb 10.
6
Acute fibrinous and organising pneumonia: a rare histopathological variant of chemotherapy-induced lung injury.急性纤维素性及机化性肺炎:化疗所致肺损伤的一种罕见组织病理学变异型。
BMJ Case Rep. 2016 Apr 6;2016:bcr2016214721. doi: 10.1136/bcr-2016-214721.
7
Retrospective evaluation of patients with organizing pneumonia: is cryptogenic organizing pneumonia different from secondary organizing pneumonia?机化性肺炎患者的回顾性评估:隐源性机化性肺炎与继发性机化性肺炎有何不同?
Tuberk Toraks. 2017 Mar;65(1):1-8.
8
SARS-CoV-2 organising pneumonia: 'Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?'.严重急性呼吸综合征冠状病毒 2 型所致机化性肺炎:“在 COVID-19 中,是否广泛存在未能识别和治疗这种普遍存在的疾病的情况?”。
BMJ Open Respir Res. 2020 Sep;7(1). doi: 10.1136/bmjresp-2020-000724.
9
Effectiveness of Steroid Treatment for SARS-CoV-2 Pneumonia With Cryptogenic Organizing Pneumonia-Like Reaction: A Case Report.类固醇治疗新冠病毒肺炎伴特发性机化性肺炎样反应的疗效:一例报告。
Disaster Med Public Health Prep. 2022 Apr;16(2):491-494. doi: 10.1017/dmp.2020.415. Epub 2020 Oct 26.
10
Delayed-onset Organizing Pneumonia Emerging after Recovery from Coronavirus Disease 2019: A Report of Three Cases Diagnosed Using Transbronchial Cryobiopsy and a Review of the Literature.COVID-19 后迟发性机化性肺炎的发生:3 例经支气管冷冻活检诊断病例报告及文献复习。
Intern Med. 2022 May 1;61(9):1403-1410. doi: 10.2169/internalmedicine.9016-21. Epub 2022 Mar 5.

引用本文的文献

1
Protracted coronavirus disease 2019 after chimeric antigen receptor-T cell therapy successfully treated with sequential multidrug therapy.嵌合抗原受体T细胞疗法后出现迁延不愈的2019冠状病毒病,经序贯多药疗法成功治疗。
Respir Med Case Rep. 2024 Sep 2;51:102104. doi: 10.1016/j.rmcr.2024.102104. eCollection 2024.
2
A case of late-onset organizing pneumonia following COVID-19 infection in a post-kidney transplant patient.一名肾移植后患者 COVID-19 感染后继发迟发性机化性肺炎。
CEN Case Rep. 2024 Oct;13(5):346-350. doi: 10.1007/s13730-023-00849-9. Epub 2024 Feb 17.
3
Organizing Pneumonia as a Pulmonary Sequela of Post-COVID-19 Syndrome in a Patient in Trinidad: A Case Report.

本文引用的文献

1
Persistent Pneumonic Consolidations due to Secondary Organizing Pneumonia in a Patient Recovering from COVID-19 Pneumonia: A Case Report and Literature Review.新冠病毒肺炎康复患者继发机化性肺炎导致的持续性肺实变:一例报告及文献综述
Infect Chemother. 2023 Mar;55(1):121-127. doi: 10.3947/ic.2022.0128. Epub 2023 Jan 9.
2
SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.SARS-CoV-2 激活肺上皮细胞促炎信号,导致 COVID-19 患者免疫失调。
EBioMedicine. 2021 Aug;70:103500. doi: 10.1016/j.ebiom.2021.103500. Epub 2021 Jul 23.
3
Sustained coronavirus disease 2019-related organizing pneumonia successfully treated with corticosteroid.
特立尼达一名患者中组织性肺炎作为新冠后综合征的肺部后遗症:一例报告
Cureus. 2023 Dec 7;15(12):e50148. doi: 10.7759/cureus.50148. eCollection 2023 Dec.
4
Delayed inflammatory pulmonary syndrome: A distinct clinical entity in the spectrum of inflammatory syndromes in COVID-19 infection?迟发性炎症性肺综合征:新型冠状病毒肺炎感染炎症综合征谱中的一种独特临床实体?
World J Crit Care Med. 2023 Sep 9;12(4):226-235. doi: 10.5492/wjccm.v12.i4.226.
5
Glucocorticoid pulse therapy in an elderly patient with post-COVID-19 organizing pneumonia: A case report.糖皮质激素脉冲疗法治疗老年新型冠状病毒肺炎后机化性肺炎1例报告
World J Clin Cases. 2023 Jun 16;11(17):4152-4158. doi: 10.12998/wjcc.v11.i17.4152.
6
Delayed organising pneumonia in an immunocompromised host after a mild COVID-19 infection.免疫功能低下宿主在轻度 COVID-19 感染后发生延迟性机化性肺炎。
BMJ Case Rep. 2023 May 16;16(5):e254737. doi: 10.1136/bcr-2023-254737.
7
ORGANIZING PNEUMONIA: AN UNUSUAL SEQUELA OF COVID-19 INFECTION.机化性肺炎:新型冠状病毒肺炎感染的一种罕见后遗症
Eur J Case Rep Intern Med. 2023 Feb 16;10(2):003787. doi: 10.12890/2023_003787. eCollection 2023.
8
Late Onset of Organizing Pneumonia Following SARS-CoV-2 Infection: A Case Report of Successful Management and Review Literature.新型冠状病毒感染后迟发性机化性肺炎:一例成功治疗病例报告及文献综述
Clin Med Insights Case Rep. 2023 Jan 26;16:11795476231152166. doi: 10.1177/11795476231152166. eCollection 2023.
9
Chronic Pulmonary Manifestations of COVID-19 Infection: Imaging Evaluation.COVID-19 感染的慢性肺部表现:影像学评估。
Radiology. 2023 Apr;307(2):e222379. doi: 10.1148/radiol.222379. Epub 2023 Jan 24.
10
The Hidden Pandemic of COVID-19-Induced Organizing Pneumonia.新冠病毒诱发的机化性肺炎这一隐匿的大流行疾病
Pharmaceuticals (Basel). 2022 Dec 16;15(12):1574. doi: 10.3390/ph15121574.
持续的 COVID-19 相关机化性肺炎经皮质类固醇治疗成功。
Respir Investig. 2021 May;59(3):377-381. doi: 10.1016/j.resinv.2020.12.005. Epub 2021 Jan 21.
4
Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.持续性 COVID-19 间质性肺病。皮质类固醇治疗的观察性研究。
Ann Am Thorac Soc. 2021 May;18(5):799-806. doi: 10.1513/AnnalsATS.202008-1002OC.
5
Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes.COVID-19 患者中皮质类固醇的使用:临床结局的系统评价和荟萃分析。
Crit Care. 2020 Dec 14;24(1):696. doi: 10.1186/s13054-020-03400-9.
6
Severe organising pneumonia following COVID-19.COVID-19 后机化性肺炎。
Thorax. 2021 Feb;76(2):201-204. doi: 10.1136/thoraxjnl-2020-216088. Epub 2020 Nov 11.
7
Organizing pneumonia of COVID-19: Time-dependent evolution and outcome in CT findings.COVID-19 机化性肺炎:CT 表现的时间依赖性演变和结局。
PLoS One. 2020 Nov 11;15(11):e0240347. doi: 10.1371/journal.pone.0240347. eCollection 2020.
8
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial.静脉注射甲泼尼龙脉冲治疗住院的严重 COVID-19 患者:一项随机对照临床试验的结果。
Eur Respir J. 2020 Dec 24;56(6). doi: 10.1183/13993003.02808-2020. Print 2020 Dec.
9
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.COVID-19 重症患者全身使用皮质类固醇与死亡率的关联:一项荟萃分析。
JAMA. 2020 Oct 6;324(13):1330-1341. doi: 10.1001/jama.2020.17023.
10
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.